<DOC>
	<DOC>NCT01638897</DOC>
	<brief_summary>The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.</brief_summary>
	<brief_title>DF4 Connector System Post-Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death, Sudden, Cardiac</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements Subject is intended to be implanted or is within 30 days postimplant of a DF4 Connector System with a Medtronic DF4 lead used for a pacing, sensing and/or defibrillation application Subject who is, or will be inaccessible for followup at a study site Subject with exclusion criteria required by local law (Europe, Central Asia [ECA] only) Implant and followup data, including any adverse device effects and system modifications at implant through the time of enrollment are unavailable</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ICD</keyword>
	<keyword>CRTD</keyword>
	<keyword>DF4</keyword>
</DOC>